WT1A-specific CD8+ T cells can be detected after in vitro expansion in healthy HLA-A2+ donors,37 yet the ability to induce effective WT1A-specific CD8+ T-cell responses in cancer patients has been less successful in WT1A-targeted vaccination studies. This evidence concerns the gene CD8A and cancer.